9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

Recruiting now

Conditions studied: Urethral Stricture

In brief

It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.

Key facts

Study ID

NCT04071925

Run by

University Hospital, Ghent

People needed

1000

Starts

2019-09-01

Expected to finish

2029-12-31

Last updated by the study team

2024-01-03

Who can join

Age: 6 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
• Patient age ≥ 6 years.
• If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.

You may not qualify if…

• Absence of signed written informed consent and thus a patient unwilling to participate.

Where it is running

• University Hospital Ghent — Ghent, Belgium (enrolling)
• Dept. of Urology, Ghent University Hospital — Ghent, Belgium

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.